115 related articles for article (PubMed ID: 26581561)
1. Identification of putative substrates for cynomolgus monkey cytochrome P450 2C8 by substrate depletion assays with 22 human P450 substrates and inhibitors.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2016 Jul; 37(5):310-3. PubMed ID: 26581561
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Evaluation for Substrate Selectivity of Cynomolgus Monkey Cytochrome P450 2C9, a New Efavirenz Oxidase.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Drug Metab Dispos; 2015 Jul; 43(7):1119-22. PubMed ID: 25948712
[TBL] [Abstract][Full Text] [Related]
3. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion/nifedipine oxidase.
Hosaka S; Murayama N; Satsukawa M; Shimizu M; Uehara S; Fujino H; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Drug Metab Dispos; 2015 Jan; 43(1):27-33. PubMed ID: 25318994
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate.
VandenBrink BM; Foti RS; Rock DA; Wienkers LC; Wahlstrom JL
Drug Metab Dispos; 2011 Sep; 39(9):1546-54. PubMed ID: 21697463
[TBL] [Abstract][Full Text] [Related]
6. Comparison of p450 enzymes between cynomolgus monkeys and humans: p450 identities, protein contents, kinetic parameters, and potential for inhibitory profiles.
Emoto C; Yoda N; Uno Y; Iwasaki K; Umehara K; Kashiyama E; Yamazaki H
Curr Drug Metab; 2013 Feb; 14(2):239-52. PubMed ID: 22963393
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
Filppula AM; Laitila J; Neuvonen PJ; Backman JT
Drug Metab Dispos; 2011 May; 39(5):904-11. PubMed ID: 21289076
[TBL] [Abstract][Full Text] [Related]
8. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
[TBL] [Abstract][Full Text] [Related]
9. Novel Cytochrome P450 2C119 Enzymes in Cynomolgus and Rhesus Macaques Metabolize Progesterone, Diclofenac, and Omeprazole.
Uno Y; Murayama N; Yamazaki H
Drug Metab Dispos; 2024 Feb; 52(3):266-273. PubMed ID: 38123944
[TBL] [Abstract][Full Text] [Related]
10. Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.
Nishimuta H; Sato K; Mizuki Y; Yabuki M; Komuro S
Drug Metab Pharmacokinet; 2011 Jun; 26(3):300-6. PubMed ID: 21383522
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of human cytochrome P4502C8 by montelukast.
Walsky RL; Obach RS; Gaman EA; Gleeson JP; Proctor WR
Drug Metab Dispos; 2005 Mar; 33(3):413-8. PubMed ID: 15608135
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism?
Uno Y; Hosaka S; Matsuno K; Nakamura C; Kito G; Kamataki T; Nagata R
Arch Biochem Biophys; 2007 Oct; 466(1):98-105. PubMed ID: 17689485
[TBL] [Abstract][Full Text] [Related]
13. Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function.
Uno Y; Iwasaki K; Yamazaki H; Nelson DR
Drug Metab Rev; 2011 Aug; 43(3):346-61. PubMed ID: 21303270
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of drug-metabolizing cytochrome P450 enzymes in cynomolgus and rhesus monkeys and common marmosets in preclinical studies for humans.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2018 Jul; 153():184-195. PubMed ID: 29277691
[TBL] [Abstract][Full Text] [Related]
15. Cynomolgus monkey CYPs: a comparison with human CYPs.
Iwasaki K; Uno Y
Xenobiotica; 2009 Aug; 39(8):578-81. PubMed ID: 19622000
[TBL] [Abstract][Full Text] [Related]
16. Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8.
Niwa T; Imagawa Y
J Pharm Pharm Sci; 2016; 19(4):423-429. PubMed ID: 28057172
[TBL] [Abstract][Full Text] [Related]
17. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone.
Uno Y; Fujino H; Kito G; Kamataki T; Nagata R
Mol Pharmacol; 2006 Aug; 70(2):477-86. PubMed ID: 16648389
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Giri P; Gupta L; Naidu S; Joshi V; Patel N; Giri S; Srinivas NR
Drug Metab Lett; 2018; 12(2):101-116. PubMed ID: 30117405
[TBL] [Abstract][Full Text] [Related]
19. Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification and characterization.
Mitsuda M; Iwasaki M; Asahi S
J Biochem; 2006 May; 139(5):865-72. PubMed ID: 16751594
[TBL] [Abstract][Full Text] [Related]
20. Toward reduction in animal sacrifice for drugs: molecular modeling of Macaca fascicularis P450 2C20 for virtual screening of Homo sapiens P450 2C8 substrates.
Rua F; Di Nardo G; Sadeghi SJ; Gilardi G
Biotechnol Appl Biochem; 2012; 59(6):479-89. PubMed ID: 23586958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
